2552 — Hua Medicine Balance Sheet
0.000.00%
- HK$3.81bn
 - HK$2.99bn
 - CNY255.89m
 
- 23
 - 62
 - 92
 - 66
 
Annual balance sheet for Hua Medicine, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,032 | 675 | 491 | 1,461 | 1,140 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.991 | 0.411 | 415 | 10.9 | 52.3 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,045 | 705 | 940 | 1,572 | 1,336 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 124 | 157 | 140 | 115 | 130 | 
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,199 | 904 | 1,121 | 1,725 | 1,527 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 107 | 107 | 188 | 252 | 330 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 466 | 453 | 842 | 1,624 | 1,663 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 732 | 450 | 280 | 101 | -135 | 
| Total Liabilities & Shareholders' Equity | 1,199 | 904 | 1,121 | 1,725 | 1,527 | 
| Total Common Shares Outstanding |